% | $
Quotes you view appear here for quick access.

Opko Health, Inc. Message Board

  • icemandios icemandios Dec 26, 2012 2:48 PM Flag

    Brazilian Pharmacy

    Dec 26, 2012 2:02:00 PM
    Copyright Business Wire 2012
    Close Ad
    Acquisition of Silcon Comércio Permits Commercial Synergies Among Subsidiaries

    Provides Commercial Platform for Near-Term Brazilian Launch of 4Kscore™ Prostate Cancer Test

    MIAMI--(BUSINESS WIRE)-- OPKO Health, Inc. (NYSE:OPK) has entered into a definitive agreement to acquire Silcon Comércio, Importacao E Exportacao de Produtos Farmaceuticos e Cosmeticos Ltda. Domiciled in Sao Paulo, Brazil, Silcon expands OPKO’s presence in Latin America and complements business activities of units in Chile and Mexico.

    Silcon broadens OPKO’s reach in Latin America with this entry into the largest market in the region. Beyond providing important cross marketing opportunities for its growing portfolio of products, Silcon represents an important strategic element for OPKO’s diagnostic business; it permits commercialization of the 4KScore™ prostate cancer test in Brazil as a reference laboratory test while OPKO obtains local approval to market its point of care microfluidics disposable test cassettes.

    “With this acquisition, OPKO establishes a footprint in the most important growth market in South America,” said Phillip Frost, M.D., Chairman and CEO of OPKO. “The acquisition allows OPKO to satisfy regulatory requirements for doing business in Brazil, which might otherwise be a prolonged process. Moreover, this platform enhances commercial synergies among our recent acquisitions and facilitates the near-term commercialization in the Brazilian market of our 4Kscore™, a novel panel of biomarkers and associated algorithm to more accurately detect and grade possible prostate cancers.”

    SortNewest  |  Oldest  |  Most Replied Expand all replies
17.89-0.29(-1.62%)May 27 4:03 PMEDT